Anavex Life Sciences Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$2.64

+0.06 (+2.33%)

As of Jun 24, 3:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,030.7% upside

Low Target $17.55

Average Target $29.85

High Target $40.51

Current Price $2.64

Current
$2.64

Target
$29.85

$17.55 $29.85 avg $40.51

Scenario Analysis

Bear Case

$17.55

564.8%

Low target

Base Case

$29.85

+1,030.7%

Avg target

Bull Case

$40.51

+1,434.5%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$13.99

-81.1% from high

52-Week Low

$2.41

+9.5% from low

Target vs 52W High

$29.85

+113.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+9.6%
AMGN Amgen Inc	Hold	44	50%	$190.87	-45.9%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+188.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-8.5%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.9%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-32.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-45.4%